{"id":"W2243903821","doi":"10.1200/jco.2014.32.4_suppl.109","title":"Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz + P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by age group.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cabazitaxel; Internal medicine; Docetaxel; Prostate cancer; Discontinuation; Adverse effect; Population; Cohort; Incidence (geometry); Cancer; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007976636,0.0002965194,0.0003283619,0.0002563031,0.0001935691,0.0004114186,0.0003457881,0.0003167707,0.002206537],"category_scores_gemma":[0.0009883002,0.0001890516,0.0006895245,0.0004715774,0.0002634811,0.0003184662,0.0004089709,0.0006473757,0.0002287391],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005437098,"about_ca_system_score_gemma":0.0009196325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002563408,"about_ca_topic_score_gemma":0.004848991,"domain_scores_codex":[0.9996,0.0001519153,0.00002208388,0.00008245632,0.00007851788,0.00006504098],"domain_scores_gemma":[0.9992873,0.0001050602,0.0002144745,0.00006648186,0.0000373892,0.0002893489],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2855713,0.009082584,0.5676324,0.000337722,0.001509377,0.0003951249,0.0002181708,0.001474811,0.00683856,0.0001997713,0.006799865,0.1199403],"study_design_scores_gemma":[0.03424416,0.07666969,0.8746858,0.00006046314,0.001521999,0.0008554399,0.0001146399,0.002560114,0.002851132,0.0001622064,0.006240717,0.00003380485],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970908,0.0004799986,0.0001976992,0.00007241754,0.000016471,0.0002687986,0.001207019,0.00001762635,0.0006491086],"genre_scores_gemma":[0.9956726,0.0002548962,0.0004333788,0.0001861696,0.00003231304,0.0002338107,0.002469252,0.000005773139,0.0007117911],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002563408,"threshold_uncertainty_score":0.007381618,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06467713322226828,"score_gpt":0.4438116790079496,"score_spread":0.3791345457856813,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}